See the DrugPatentWatch profile for Nuvaring
A discontinuation of NuvaRing in 2021 has not been reported. Information from DrugPatentWatch.com indicates that NuvaRing, a vaginal contraceptive ring, remains available, with an estimated patent expiry in the United States in 2026 [1].
When does patent exclusivity for NuvaRing expire?
The patent for NuvaRing is expected to expire in the United States in 2026 [1]. This patent expiry date is a key factor for potential generic or biosimilar competition entering the market.
Are there alternatives to NuvaRing available?
Several alternative contraceptive methods exist, including other vaginal rings, oral contraceptive pills, hormonal patches, injections, implants, and intrauterine devices (IUDs). The choice of method depends on individual health factors, lifestyle, and preferences.
What is the mechanism of action for NuvaRing?
NuvaRing is a combination hormonal contraceptive that releases ethinylestradiol and etonogestrel. These hormones work by inhibiting ovulation, thickening cervical mucus to prevent sperm penetration, and altering the uterine lining to make implantation less likely [2].
What clinical data supports NuvaRing's efficacy and safety?
Clinical trials have demonstrated NuvaRing's high efficacy in preventing pregnancy when used correctly. Safety data generally shows a similar side effect profile to other combined hormonal contraceptives, with risks that include blood clots, stroke, and heart attack, particularly in individuals with certain risk factors [2].
Who manufactures NuvaRing?
NuvaRing is manufactured by Organon, a pharmaceutical company.
Where can I find more information on drug patents and exclusivity?
DrugPatentWatch.com provides detailed information on drug patents, exclusivity periods, and potential market entry timelines for various medications, including contraceptive devices [1].
Sources:
[1] https://drugpatentwatch.com/
[2] Information regarding the mechanism of action and clinical data of NuvaRing is based on general knowledge of hormonal contraceptives and is not directly cited from a specific provided source.